The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ label warning that higher doses and longer-term use carry risks including overdose and death, STAT’s Lev Facher reports. The new rules also require warnings about the dangers of rapidly reducing someone’s dose or discontinuing altogether.

Over a dozen states filed a lawsuit Friday against the Trump administration over what they describe as an unlawful intimidation campaign against hospitals and other providers of gender-affirming ca | Blue state plaintiffs say that investigations and threats of prosecution targeting children's hospitals and other providers of gender-affirming care for adolescents are unlawful and intrude upon states' rights.

Democratic attorneys general and others are accusing President Donald Trump of intimidating hospitals into dropping gender-affirming care for transgender youth.